Generic drugs trade association Medicines for Europe has urged EU health ministers to take action to address the impact of inflation on the supply of essential medicines, maintaining that the “industry cannot operate in an environment combining rampant cost inflation with policies that continuously lower prices” in an open letter.
“For the last decade, off-patent medicines have been subject to strict price regulation, budget austerity measures, and lowest-price tender rules, causing substantial price erosion and an
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?